Abstract
The present study was conducted to determine whether Valyl-Tyrosine (VY) has an antihypertensive effect on high-normal blood pressure and mild essential hypertension, as well as spontaneous hypertensive rats (SHR). A randomised double-blind placebo-controlled study was carried out on 29 volunteers. A 100-ml drink containing 3 mg of VY and a 100-ml placebo drink were prepared. The subjects were grouped as VY(16M/1F, 45.5 ± 3.2 years, 146.4 ± 2.3/90.5 ± 1.8 mm Hg) and the placebo (P) (11 M/1F, 48.8 ± 3.0 years, 145.5 ± 2.4/92.3 ± 1.8 mm Hg). At 3 weeks of the control (C) period, a VY- or P-drink was administered twice a day for 4 weeks in the experimental (E) period and during the 4-week recovery period, neither drink was given to either group. Blood pressure (BP) was measured every week in the morning in the sitting position. Blood specimens were taken on the last day of the C and E periods. In the VY-group, reduction in systolic (S) and diastolic (D) BP was 9.7 and 5.3 mm Hg (P < 0.001) at 1 week, and 9.3 and 5.2 mm hg (P < 0.001) at 4 weeks, following the start of the e period, respectively. neither sbp nor dbp changed in the p-group. bp in the vy-group increased gradually by the end of the recovery period. plasma angiotensin (ang) i and vy concentrations significantly increased while ang ii and aldosterone significantly decreased after vy administration in the vy-group. vy appeared to have a significant antihypertensive effect on mild hypertensive subjects via ang i-converting enzyme inhibition, as well as shr, but no adverse effects could be detected at all.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kawasaki, T., Seki, E., Osajima, K. et al. Antihypertensive effect of Valyl-Tyrosine, a short chain peptide derived from sardine muscle hydrolyzate, on mild hypertensive subjects. J Hum Hypertens 14, 519–523 (2000). https://doi.org/10.1038/sj.jhh.1001065
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.jhh.1001065
Keywords
This article is cited by
-
Oral intake of rice overexpressing ubiquitin ligase inhibitory pentapeptide prevents atrophy in denervated skeletal muscle
npj Science of Food (2021)
-
A trip of peptides to the brain
Food Production, Processing and Nutrition (2020)
-
Brain-transportable dipeptides across the blood-brain barrier in mice
Scientific Reports (2019)
-
Acid and alkaline solubilization (pH shift) process: a better approach for the utilization of fish processing waste and by-products
Environmental Science and Pollution Research (2018)
-
Insertion of antihypertensive peptides in acidic subunit from amaranth 11S induces contrasting effects in stability
Applied Microbiology and Biotechnology (2018)